| Vial description: |
SPCA, Proconvertin |
| Category: |
primary antibody |
| Raised in: |
Sheep |
| Clone: |
1 vial |
| Form: |
Ig Fraction |
| Reactivity: |
Human |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
P08709 |
| Application: |
INELISAUT, ELISA |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Aplha, Complex subunit associated factors are involved in hybridoma growth, Eosinohils, Freeze thaw will destroy a percentage in every cycle and should be avoided, NFKB 105 subunit for example is a polypetide gene enhancer of genes in B cells, eritroid proliferation and derived from promotor binding stimulating subunits on the DNA binding complex, transcription related growth factors and stimulating factors or repressing nuclear factors are complex subunits of proteins involved in cell differentiation, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
Coagulation factor VII (F7) |
| Short name: |
anti-Coagulation factor VII (F7) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
antibody to-Coagulation factor VII (coagulation factor VII (serum prothrombin conversion accelerator)) (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
Extracellular, F7 and IDBG-134155 and ENSMUSG00000031443 and 14068, F7 and IDBG-52192 and ENSG00000057593 and 2155, F7 and IDBG-634312 and ENSBTAG00000007411 and 617960, SPCA, extrinsic pathway and biological process this GO :0007623 and circadian rhythm and biological process this GO :0008236 and serine-type peptidase activity and molecular function this GO :0009725 and response to hormone and biological process this GO :0010641 and positive regulation of platelet-derived growth factor receptor signaling pathway and biological process this GO :0014070 and response to organic cyclic compound and biological process this GO :0017187 and peptidyl-glutamic acid carboxylation and biological process this GO :0030194 and positive regulation of blood coagulation and biological process this GO :0030335 and positive regulation of cell migration and biological process this GO :0031100 and organ regeneration and biological process this GO :0031667 and response to nutrient levels and biological process this GO :0031982 and vesicle and cellular component this GO :0032571 and response to vitamin K and biological process this GO :0043627 and response to estrogen and biological process this GO :0043687 and post-translational protein modification and biological process this GO :0044267 and cellular protein metabolic process and biological process this GO :0050927 and positive regulation of positive chemotaxis and biological process this GO :0051897 and positive regulation of protein kinase B signaling and biological process this GO :0060416 and response to growth hormone and biological process, serine-type peptidase activity, this GO :0001948 and glycoprotein binding and molecular function this GO :0002690 and positive regulation of leukocyte chemotaxis and biological process this GO :0003824 and catalytic activity and molecular function this GO :0004175 and endopeptidase activity and molecular function this GO :0004252 and serine-type endopeptidase activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005509 and calcium ion binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005788 and endoplasmic reticulum lumen and cellular component this GO :0005796 and this GO lgi lumen and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006508 and proteolysis and biological process this GO :0007596 and blood coagulation and biological process this GO :0007598 and blood coagulation, this GO :0001948 : glycoprotein binding, this GO :0001948 : glycoprotein binding and also this GO :0003824 : catalytic activity and also this GO :0004175 : endopeptidase activity and also this GO :0004252 : serine-type endopeptidase activity and also this GO :0005102 : receptor binding and also this GO :0005509 : calcium ion binding and also this GO :0005515 : protein binding and also this GO :0008236 : serine-type peptidase activity, this GO :0003824 : catalytic activity, this GO :0004175 : endopeptidase activity, this GO :0004252 : serine-type endopeptidase activity, this GO :0005102 : receptor binding, this GO :0005509 : calcium ion binding, this GO :0005515 : protein binding, this GO :0008236 : serine-type peptidase activity, coagulation factor VII (serum prothrombin conversion accelerator) |
| Identity: |
3544 |
| Gene: |
F7 |
More about : F7 |
| Long gene name: |
coagulation factor VII |
| Synonyms gene name: |
coagulation factor VII (serum prothrombin conversion accelerator) |
| Synonyms name: |
eptacog alfa FVII coagulation protein factor VII |
| Locus: |
13q34 |
| Discovery year: |
2001-06-22 |
| Entrez gene record: |
2155 |
| Pubmed identfication: |
3264725 2511201 |
| RefSeq identity: |
NM_000131 |
| Classification: |
Gla domain containing |
| Havana BLAST/BLAT: |
OTTHUMG00000017373 |
| Locus Specific Databases: |
LRG_554 |